JHP Pharmaceuticals, a US based contract manufacturing services provider, has joined hands with an undisclosed biotech firm for the production of clinical trial batches of a drug for treating heart failure.
Subscribe to our email newsletter
The company offers contract manufacturing of ophthalmic/otic and sterile injectables products, for pharmaceutical and biotech firms.
JHP Pharma’s sterile manufacturing facility, situated in Rochester Michigan and covers over 80 acres of land and includes a 171,000sqft production building and warehouse.
JHP Pharma president and CEO Stuart Hinchen said during the last seven months, they have completed FDA and EMA audits and entered agreements with five new customers.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.